PMV Pharmaceuticals Inc reports results for the quarter ended in December - Earnings Summary

Pmv Pharmaceuticals

01/03/2022 22:01

* PMV Pharmaceuticals Inc  PMVP.OQ  reported a quarterly
adjusted
loss of 40 cents​​ per share for the quarter ended in December.
The mean expectation of six analysts for the quarter was for a
loss of 35 cents per share.
    * Reported revenue was zero​;  analysts expected zero. 
    * PMV Pharmaceuticals Inc's reported EPS for the quarter was
a
loss of 40 cents​.
    * The mean earnings estimate of analysts was unchanged in
the last
three months.​ 
    * In the last 30 days there have been no earnings estimate
revisions by analysts covering the company. 
    * PMV Pharmaceuticals Inc shares had fallen by 31.4% this
quarter.
    * The company reported a quarterly loss of $18.36 million.
    * Wall Street's median 12-month price target for PMV
Pharmaceuticals Inc is $62.00 
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 6 "strong buy" or "buy," 1
"hold" and no "sell" or "strong sell." 

This summary was machine generated March 1 at 10:00 p.m.  ​All
figures in US dollars unless otherwise stated